Pfizer (PFE) earnings Q4 2025
Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while…
Tariffs on South Korean autos, pharma, to rise to 25%
U.S. President Donald Trump speaks at the 2025 Asia-Pacific Economic Cooperation (APEC) CEO Summit in Gyeongju, South Korea,…
Why a week without blockbuster M&A was actually fantastic
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Kennedy’s SSRI rhetoric fuels distrust amid teen mental health crisis
While his war on vaccines may be getting more attention, health secretary Robert F. Kennedy Jr. is coming…
Childhood vaccine schedule slashed, ‘unknown risks’ of vaccination cited
WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response to an…
Pill version of Novo Nordisk’s Wegovy approved, possibly widening access
The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug…
Nine pharma companies ink deals with Trump to lower drug prices
U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White House December 19,…
Trump reclassifies cannabis to Schedule III, easing weed restrictions
U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in…
Eli Lilly’s weight loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
RFK Jr.’s ACIP panel recommends delay in newborn hepatitis B vaccination
A panel that advises on U.S. vaccine policy voted on Friday to recommend a delay in when most…
RFK Jr.’s vaccine panel to vote on hepatitis B shot for babies
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee is scheduled to vote Thursday on…
Top drug regulator Richard Pazdur set to leave the FDA
WASHINGTON — Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration…